Published in Br J Pharmacol on August 01, 2001
Statins Reduce the Risk of Cirrhosis and Its Decompensation in Chronic Hepatitis B Patients: A Nationwide Cohort Study. Am J Gastroenterol (2016) 2.80
Strategies for blocking the fibrogenic actions of connective tissue growth factor (CCN2): From pharmacological inhibition in vitro to targeted siRNA therapy in vivo. J Cell Commun Signal (2009) 1.33
The role of connective tissue growth factor (CTGF/CCN2) in skeletogenesis. Crit Rev Eukaryot Gene Expr (2011) 1.11
Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatin. Blood Coagul Fibrinolysis (2008) 1.11
Lysophosphatidic acid and renal fibrosis. Biochim Biophys Acta (2008) 1.04
Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. Am J Pathol (2003) 1.03
Cell-specific toxicity of fibrates in human embryonal rhabdomyosarcoma cells. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.82
Beneficial Effects of Statins on the Rates of Hepatic Fibrosis, Hepatic Decompensation, and Mortality in Chronic Liver Disease: A Systematic Review and Meta-Analysis. Am J Gastroenterol (2017) 0.79
Vectorial secretion of CTGF as a cell-type specific response to LPA and TGF-β in human tubular epithelial cells. Cell Commun Signal (2012) 0.77
Lovastatin Inhibits Low Molecular Weight Hyaluronan Induced Chemokine Expression via LFA-1 and Decreases Bleomycin-Induced Pulmonary Fibrosis. Int J Biomed Sci (2014) 0.76
Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis. Thorax (2016) 0.75
A Phase II Study to Prevent Radiation-induced Rectal Injury With Lovastatin. Am J Clin Oncol (2016) 0.75
Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers. Cell Death Dis (2017) 0.75
Simvastatin ameliorates low-dose streptozotocin-induced type 2 diabetic nephropathy in an experimental rat model. Int J Clin Exp Med (2015) 0.75
Statins and the risk of cirrhosis in hepatitis B or C patients: a systematic review and dose-response meta-analysis of observational studies. Oncotarget (2017) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Rho GTPases and signaling networks. Genes Dev (1997) 11.70
Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem (1996) 8.08
The modular architecture of a new family of growth regulators related to connective tissue growth factor. FEBS Lett (1993) 3.99
The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res (1999) 3.90
Connective tissue growth factor: a mediator of TGF-beta action on fibroblasts. Cytokine Growth Factor Rev (1997) 3.86
Current perspectives on statins. Circulation (2000) 3.83
Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin. Lancet (1994) 3.72
Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J (1999) 3.28
A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ (1996) 3.05
Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol (1996) 2.70
Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. FASEB J (1999) 2.50
Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J (1998) 2.20
Expression of connective tissue growth factor in human renal fibrosis. Kidney Int (1998) 2.19
Lysophosphatidic acid receptors. Mol Pharmacol (2000) 2.06
Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol (1996) 1.79
Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem (1999) 1.73
Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation (1997) 1.67
Cell cycle-specific effects of lovastatin. Proc Natl Acad Sci U S A (1991) 1.54
Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. Mol Pharmacol (2001) 1.51
Connective tissue growth factor: potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int (2000) 1.41
Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation (2000) 1.41
Transforming growth factor beta induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell Growth Differ (1997) 1.40
Expression of connective tissue growth factor in human renal fibroblasts: regulatory roles of RhoA and cAMP. J Am Soc Nephrol (2001) 1.22
Induction of connective tissue growth factor by activation of heptahelical receptors. Modulation by Rho proteins and the actin cytoskeleton. J Biol Chem (2000) 1.21
Connective tissue growth factor: a novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int J Biochem Cell Biol (1998) 1.21
Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types. Biochim Biophys Acta (1997) 1.15
The role of lipids in renal disease: future challenges. Kidney Int Suppl (2000) 1.11
Clinical pharmacokinetics of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. Clin Pharmacokinet (1996) 1.07
Role of Rho protein in lovastatin-induced breakdown of actin cytoskeleton. J Pharmacol Exp Ther (1997) 1.04
Signal transduction pathways responsible for serotonin-mediated prostaglandin G/H synthase expression in rat mesangial cells. J Biol Chem (1994) 1.04
Lovastatin modulates in vivo and in vitro the plasminogen activator/plasmin system of rat proximal tubular cells: role of geranylgeranylation and Rho proteins. J Am Soc Nephrol (1998) 0.98
Transforming growth factor-beta in renal disease. Kidney Blood Press Res (1998) 0.98
Transcriptional regulation of connective tissue growth factor by cortisol in osteoblasts. Am J Physiol Endocrinol Metab (2000) 0.94
Lovastatin inhibits transforming growth factor-beta1 expression in diabetic rat glomeruli and cultured rat mesangial cells. J Am Soc Nephrol (2000) 0.92
Connective tissue growth factor expression in the rat remnant kidney model and association with tubular epithelial cells undergoing transdifferentiation. Vet Pathol (2000) 0.89
Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cells. Basic Res Cardiol (1999) 0.88
TGF-beta1 stimulation of fibronectin transcription in cultured human lung fibroblasts requires active geranylgeranyl transferase I, phosphatidylcholine-specific phospholipase C, protein kinase C-delta, and p38, but not erk1/erk2. Arch Biochem Biophys (2000) 0.87
Inhibition of type I collagen gene expression in normal and systemic sclerosis fibroblasts by a specific inhibitor of geranylgeranyl transferase I. Arthritis Rheum (2000) 0.86
Low-density lipoprotein-induced expression of interleukin-6, a marker of human mesangial cell inflammation: effects of oxidation and modulation by lovastatin. Biochem Biophys Res Commun (2000) 0.86
Human renal fibroblast cell lines (tFKIF and tNKF) are new tools to investigate pathophysiologic mechanisms of renal interstitial fibrosis. Exp Nephrol (1995) 0.86
Lovastatin reduces glomerular macrophage influx and expression of monocyte chemoattractant protein-1 mRNA in nephrotic rats. Am J Kidney Dis (1998) 0.85
Lovastatin-induced inhibition of renal epithelial tubular cell proliferation involves a p21ras activated, AP-1-dependent pathway. Kidney Int (1997) 0.82
Inhibition of protein isoprenylation impairs rho-regulated early cellular response to genotoxic stress. Mol Pharmacol (2000) 0.81
Effect of lipid-lowering strategies on tubular cell biology. Kidney Int Suppl (1999) 0.80
Human mesangial cell production of monocyte chemoattractant protein-1: modulation by lovastatin. Kidney Int (1995) 0.80
Inhibition of Ras prenylation: a signaling target for novel anti-cancer drug design. Anticancer Drug Des (1997) 0.79
In vitro effects of simvastatin on tubulointerstitial cells in a human model of cyclosporin nephrotoxicity. Am J Physiol (1999) 0.78
Prevention of progression of renal fibrosis: how far are we? Kidney Int Suppl (1996) 0.78
G-protein-mediated signaling in cholesterol-enriched arterial smooth muscle cells. 1. Reduced membrane-associated G-protein content due to diminished isoprenylation of G-gamma subunits and p21ras. Biochemistry (1997) 0.77
Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett (1996) 1.30
Expression of connective tissue growth factor in human renal fibroblasts: regulatory roles of RhoA and cAMP. J Am Soc Nephrol (2001) 1.22
Induction of connective tissue growth factor by activation of heptahelical receptors. Modulation by Rho proteins and the actin cytoskeleton. J Biol Chem (2000) 1.21
Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs. Am J Respir Cell Mol Biol (1998) 1.04
Upregulation of CD40 and CD40 ligand (CD154) in patients with moderate hypercholesterolemia. Circulation (2001) 1.04
Signal transduction pathways responsible for serotonin-mediated prostaglandin G/H synthase expression in rat mesangial cells. J Biol Chem (1994) 1.04
Control of prostanoid synthesis: role of reincorporation of released precursor fatty acids. Prostaglandins (1986) 1.03
Antineutrophil cytoplasmic antibodies induce human monocytes to produce oxygen radicals in vitro. Arthritis Rheum (2001) 1.00
Interleukin-1-induced cyclooxygenase 2 expression is suppressed by cyclosporin A in rat mesangial cells. Kidney Int (1994) 0.97
Effects of glucocorticoids on the TPA-induced monocytic differentiation. J Leukoc Biol (1992) 0.97
Rat pulmonary cyclooxygenase-2 expression in response to endotoxin challenge: differential regulation in the various types of cells in the lung. Am J Pathol (2000) 0.95
Coordinate expression of cyclooxygenase-2 and renin in the rat kidney in renovascular hypertension. Hypertension (1998) 0.93
Purification of human leukotriene C4 synthase. Proc Natl Acad Sci U S A (1992) 0.93
An increase in myeloid-related protein serum levels precedes acute renal allograft rejection. J Am Soc Nephrol (2001) 0.90
Glucocorticoid-induced reduction of prostanoid synthesis in TPA-differentiated U937 cells is mainly due to a reduced cyclooxygenase activity. Biochem Pharmacol (1990) 0.89
Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis. Inflamm Res (1998) 0.89
Altered arachidonic acid metabolism during differentiation of the human monoblastoid cell line U937. Biochim Biophys Acta (1990) 0.89
Contribution of Src-FAK signaling to the induction of connective tissue growth factor in renal fibroblasts. Kidney Int (2006) 0.87
Mycophenolate mofetil inhibits rat and human mesangial cell proliferation by guanosine depletion. Nephrol Dial Transplant (1999) 0.86
Localization of cyclooxygenase-2 and prostaglandin E2 receptor EP3 in the rat lumbar spinal cord. J Neuroimmunol (1998) 0.84
Cytosolic phospholipase A2 from human monocytic cells: characterization of substrate specificity and Ca(2+)-dependent membrane association. Biochem J (1993) 0.84
Differential regulation of chemokines by leukemia inhibitory factor, interleukin-6 and oncostatin M. Kidney Int (1997) 0.83
Up-regulation of cyclooxygenase-1 in neuroblastoma cell lines by retinoic acid and corticosteroids. J Neurochem (2001) 0.82
Characterization of phospholipase A2 in monocytic cell lines. Functional and biochemical aspects of membrane association. Biochem J (1991) 0.82
Differentiation-associated expression of prostaglandin G/H synthase in monocytic cells. FEBS Lett (1993) 0.81
Cytokine-induced expression of leukemia inhibitory factor in renal mesangial cells. Kidney Int (1994) 0.81
Modulation of prostaglandin G/H synthase expression in mesangial cells transfected by pp60c-src proto-oncogene. Exp Cell Res (1996) 0.80
Upregulation of cyclooxygenase-1 and the PGE2 receptor EP2 in rat and human mesangioproliferative glomerulonephritis. Inflamm Res (2000) 0.79
Regulation of prostaglandin synthesis in Madin Darby canine kidney cells: role of prostaglandin G/H synthase and secreted phospholipase A2. Biochim Biophys Acta (1996) 0.79
Alterations in glycosylation and lectin pattern during phorbol ester-induced differentiation of U937 cells. Cancer Res (1990) 0.79
Interference of corticosteroids with prostaglandin E2 synthesis at the level of cyclooxygenase-2 mRNA expression in kidney cells. Biochem Pharmacol (1996) 0.78
Glucocorticoids inhibit oncostatin M-induced phospholipase A2 gene expression in human hepatoma cells. Cytokine (1997) 0.77
Monocytic-endothelial cell interaction: regulation of prostanoid synthesis in human coculture. J Leukoc Biol (1997) 0.77
Modulation of phospholipase D stimulation in c-src transfected mesangial cells. J Lipid Mediat Cell Signal (1997) 0.77
Differential effect of dexamethasone on the regulation of phospholipase A2 and prostanoid synthesis in undifferentiated and phorbolester-differentiated U937 cells. J Cell Biochem (1989) 0.77
Phospholipase A2 activity in T-lymphocytes. FEBS Lett (1986) 0.75
Cox-2 and osteopontin in cocultured platelets and mesangial cells: role of glucocorticoids. Kidney Int (2000) 0.75